Apple is reportedly developing its smartwatch technologies through new partnerships

By Catherine Sturman
Apple is continually developing its smartwatch capabilities, understanding that its innovations within healthcare will open the door to further market o...

Apple is continually developing its smartwatch capabilities, understanding that its innovations within healthcare will open the door to further market opportunities.

It has been reported that Apple is working with Stanford clinicians and American Well to further its smartwatch technologies and enable it to detect common heart conditions and abnormalities through the use of sensors.

If successful, the company will see a steady rise in revenue by catering towards high-risk patients, with information that is over 90% accurate. Both Stanford and American Well have declined to comment.

Related stories

At present, Apple’s Series 3 provides useful information surrounding a user’s health as a result of its interest in fitness applications. The Apple Watch app can also detect any irregularities with over 95% accuracy.

Apple’s previous partnership with health app Cardiogram has also highlighted the company’s focus in cardiology and health screening. In 2016,

However, through this new partnership, Apple will develop its technology further, especially with regards to health recovery times, and whether there is the potential for undiagnosed health conditions, such as atrial fibrillation, to be bought to light.

Share

Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma